These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6198069)

  • 1. Metastatic breast cancer in males. Assessment of endocrine therapy.
    Patel JK; Nemoto T; Dao TL
    Cancer; 1984 Mar; 53(6):1344-6. PubMed ID: 6198069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment.
    Murray RM; Pitt P
    Breast Cancer Res Treat; 1981; 1(2):91-5. PubMed ID: 7348572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
    Kaye SB; Woods RL; Fox RM; Coates AS; Tattersall MH
    Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of metastatic breast cancer with aminoglutethimide.
    Kaye SB; Woods RL; Fox RM; Tattersall MH
    Aust N Z J Med; 1981 Aug; 11(4):370-4. PubMed ID: 7030292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen (Nolvadex) versus adrenalectomy in metastatic breast cancer.
    Nemoto T; Patel J; Rosner D; Dao TL
    Cancer; 1984 Mar; 53(6):1333-5. PubMed ID: 6692322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience.
    Murray RM; Pitt P
    Cancer Res; 1982 Aug; 42(8 Suppl):3437s-3441s. PubMed ID: 6211229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH; Manni A; Arafah BM
    Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal treatment of disseminated male breast cancer.
    Lopez M; Di Lauro L; Lazzaro B; Papaldo P
    Oncology; 1985; 42(6):345-9. PubMed ID: 2933617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer.
    Harvey HA; Lipton A; White DS; Santen RJ; Boucher AE; Shafik AS; Dixon RJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3451s-3453s. PubMed ID: 6177405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
    Brufman G; Biran S
    Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is medullary carcinoma of the breast hormone dependent?
    Patel JK; Nemoto T; Dao TL
    J Surg Oncol; 1983 Dec; 24(4):290-1. PubMed ID: 6656256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen.
    Gale KE; Andersen JW; Tormey DC; Mansour EG; Davis TE; Horton J; Wolter JM; Smith TJ; Cummings FJ
    Cancer; 1994 Jan; 73(2):354-61. PubMed ID: 8293400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglutethimide in postmenopausal breast cancer refractory to multiple hormonal and cytostatic treatments.
    Zambetti M; Brambilla C; Tancini G; Bonadonna G
    Tumori; 1987 Aug; 73(4):369-73. PubMed ID: 3660475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
    Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
    Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to aminoglutethimide after failure of tamoxifen therapy in breast cancer.
    Sutherland CM; Muchmore JH; Carter RD
    South Med J; 1985 Aug; 78(8):987-9. PubMed ID: 4023793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral adrenalectomy in treatment of disseminated breast cancer.
    Galbut DL; Wallack MK; Brown AS; Rosato E; Johnson J; Rosato FE
    Am J Surg; 1976 Mar; 131(3):267-9. PubMed ID: 56896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
    Brufman G; Biran S
    Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.